Balyasny Asset Management’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.03M | Buy |
|
|||||
|
2025
Q1 | $556K | Sell |
|
|||||
|
2024
Q4 | $833K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $397K | Buy |
|
|||||
|
2023
Q3 | $164K | Buy |
|
|||||
|
2023
Q2 | $249K | Buy |
|
|||||
|
2023
Q1 | $84.9K | Sell |
|
|||||
|
2022
Q4 | $70.2K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $74K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $76K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $274K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $821K | Buy |
|